Literature DB >> 6425563

Malignant soft tissue tumors of nerve sheath origin.

R N Nambisan, U Rao, R Moore, C P Karakousis.   

Abstract

Thirty-one patients with neurogenic sarcomas treated at Roswell Park Memorial Institute (RPMI) during a 10-year period were studied. The mean follow-up is 35.5 months. A specific nerve of origin could not be identified in 61.3% of patients. The most frequent site was the proximal lower extremity (38.7%). The only presenting symptom was enlarging mass in 67.7%. There was association with Von Recklinghausen's disease in 42% of the cases. Survival was significantly worse in tumors with Von Recklinghausen's disease (25.6%) compared to patients with solitary malignant schwannomas (50.9%). Twelve of 18 patients who had adequate surgical treatment initially remain disease-free, whereas only 2 of 11 patients referred following partial excision or recurrence remain disease-free (P less than 0.02). Eleven of 18 patients with grade I or II tumor are disease-free, whereas 2 of 10 patients with grade III tumor are disease-free (P less than 0.05). Resection of the sciatic nerve with wide excision is accompanied with a good functional result.

Entities:  

Mesh:

Year:  1984        PMID: 6425563     DOI: 10.1002/jso.2930250410

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  14 in total

1.  Malignant Peripheral Nerve Sheath Tumor Presenting as a Massive Intra-abdominal Mass.

Authors:  P J Vincent; S Rajagopalan; S Jetley; A Sen; P Singh; Rohit Sharma
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 2.  Neoplasms associated with germline and somatic NF1 gene mutations.

Authors:  Sachin Patil; Ronald S Chamberlain
Journal:  Oncologist       Date:  2012-01-12

3.  Diffuse leptomeningeal seeding from a malignant spinal cord astrocytoma in a child with neurofibromatosis.

Authors:  B L Maria; L L Cafferty; H S Singer; J I Epstein; B S Carson
Journal:  J Neurooncol       Date:  1986       Impact factor: 4.130

4.  Management of great vessels and nerves in limb-salvage surgery for bone and soft tissue tumors.

Authors:  Deng-xing Lun; Yong-cheng Hu; Hong-chao Huang
Journal:  Orthop Surg       Date:  2013-11       Impact factor: 2.071

5.  Malignant Peripheral Nerve Sheath Tumour of the Small Bowel Presenting with Intussusception and Perforation: a Double Jeopardy?

Authors:  Ananth P Abraham; Joshua Franklyn; Jagan Chandramohan; Pranay Gaikwad; John C Muthusami
Journal:  Indian J Surg Oncol       Date:  2016-11-08

6.  Extremity malignant peripheral nerve sheath tumors (neurogenic sarcomas): a 10-year experience.

Authors:  J N Vauthey; J M Woodruff; M F Brennan
Journal:  Ann Surg Oncol       Date:  1995-03       Impact factor: 5.344

Review 7.  Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1.

Authors:  Matthias Kolberg; Maren Høland; Trude H Agesen; Helge R Brekke; Knut Liestøl; Kirsten S Hall; Fredrik Mertens; Piero Picci; Sigbjørn Smeland; Ragnhild A Lothe
Journal:  Neuro Oncol       Date:  2012-11-15       Impact factor: 12.300

8.  Intraoral presentation of multiple malignant peripheral nerve sheath tumors associated with neurofibromatosis-1.

Authors:  Mahija Janardhanan; S Rakesh; Rb Vinod Kumar
Journal:  J Oral Maxillofac Pathol       Date:  2011-01

9.  Malignant peripheral nerve sheath tumors (MPNST)--clinicopathological study and treatment outcome of twenty-four cases.

Authors:  Madhabananda Kar; S V Suryanarayana Deo; Nootan Kumar Shukla; Ajay Malik; Sidharth DattaGupta; Bidhu Kumar Mohanti; Sanjay Thulkar
Journal:  World J Surg Oncol       Date:  2006-08-22       Impact factor: 2.754

10.  Survival in Malignant Peripheral Nerve Sheath Tumours: A Comparison between Sporadic and Neurofibromatosis Type 1-Associated Tumours.

Authors:  D E Porter; V Prasad; L Foster; G F Dall; R Birch; R J Grimer
Journal:  Sarcoma       Date:  2009-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.